RNLX Renalytix AI PLC ADRs

Renalytix AI Plc manufactures medical devices and equipment. It offers artificial intelligence for kidney disease. The company was founded on March 15,2018 and is headquartered in Penarth, the United Kingdom. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:RENX.

$1.35  -0.04 (-2.78%)
As of 10/05/2022 14:53:13 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  United Kingdom
Country of incorporation:  
IPO date:  07/17/2020
Outstanding shares:  37,445,922
Average volume:  97,669
Market cap:   $47,556,321
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   -1.25
PB ratio:   0.70
PS ratio:   19.67
Return on equity:   -96.12%
Net income %:   -1,820.68%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy